Inactive Instrument

Hubei Minkang Pharmaceutical Ltd. Stock price

Equities

HBMK

US44352W1018

Pharmaceuticals

Hubei Minkang Pharmaceutical Ltd. (Hubei), through its subsidiaries, HBMK Pharmaceutical Limited (HBMK) and Hubei Minkang PRC, produces and markets traditional Chinese medicines (TCM). The Company's products include product types include pills, tablets, capsules, granules, oral liquids, syrups, mixtures and injections and dosages. It markets its products to the United States, Japan, Canada, Singapore, Malaysia, Thailand and Hong Kong. The Company's principal Chinese products include Yinxing Damo Zhusheye, An Ka Huangmin Jiaonang, Xumeian Capsule, Wei C Yinqiao Pian and Shuxin Koufouye. Hubei Minkang PRC's selling product, Wei C is approved by the United States Food and Drug Administration (FDA) for sale in the United States. Hubei Minkang PRC markets its products in approximately 26 provinces in China, and has a distribution network which covers over 1200 hospitals and 10100 medical halls (TCM pharmacies).
More about the company
  1. Stock
  2. Equities
  3. Stock Hubei Minkang Pharmaceutical Ltd. - OTC Markets